H.C. Wainwright initiated coverage on Valneva SE with a new price target

8/3/22 7:27:56 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

H.C. Wainwright initiated coverage of Valneva SE with a rating of Buy and set a new price target of $34.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$VALN

Date	Price Target	Rating	Analyst
8/3/2022	$34.00	Buy	H.C. Wainwright